Article

Rheumatoid Arthritis Quiz: What Factors Increase Risk of Developing RA?

This week's rheumatoid arthritis quiz was developed by Fotios Koumpouras, MD, Director of Education and Training and Director of the Yale Lupus Program at Yale School of Medicine.

How often is rheumatoid arthritis (RA) seronegative?

A. ~10%

B. ~50%

C. ~1%

D. ~30%


Related Videos
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
Related Content
Rheumatology Month in Review: September 2024
October 6th 2024

Rheumatology Month in Review: September 2024

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
investigator Dr Nam Huynh, senior research fellow, UCL Medical Physics and Biomedical Engineering
October 3rd 2024

Rapid, High-Fidelity Medical Imaging Reveals Cancer, Arthritis in New Research

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Megan Hanlon, PhD, former post-doctoral fellow in molecular rheumatology, Trinity College Dublin, Brigham and Women's, Harvard University
October 2nd 2024

New Research Identifies Predictive Changes in Joint Microenviroment Prior to RA Onset

Victoria Johnson
M. Elaine Husni, MD, MPH, Vice Chair of Rheumatology, and Director, Arthritis and Musculoskeletal Center, and Staff Physician, Orthopedic and Rheumatologic Institute, Cleveland Clinic, and Assistant Professor, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Published: October 2nd 2024 | Updated: October 2nd 2024

Bimekizumab Improves Pain, Fatigue, and More in Active Psoriatic Arthritis Over Placebo

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.